Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2020 | 2018 | 2017 | 2016 | 2015 | 2013
Number of items: 12.

2020

Berthold, F., Faldum, A., Ernst, A., Boos, J., Dilloo, D., Eggert, A., Fischer, M., Fruehwald, M., Henze, G., Klingebiel, T., Kratz, C., Kremens, B., Krug, B., Leuschner, I, Schmidt, M., Schmidt, R., Schumacher-Kuckelkorn, R., von Schweinitz, D., Schilling, F. H., Theissen, J., Volland, R., Hero, B. and Simon, T. (2020). Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR. Ann. Oncol., 31 (3). S. 422 - 430. AMSTERDAM: ELSEVIER. ISSN 1569-8041

2018

Ackermann, S., Cartolano, M., Hero, B., Roderwieser, A., Bartenhagen, C., Rosswog, C., Hertwig, F., Simon, T., Eggert, A., Speleman, F., Buettner, R., O'Sullivan, R., Thomas, R., Berthold, F., Vandesompele, J., Schramm, A., Westermann, F., Schulte, J., Peifer, M. and Fischer, M. (2018). A Mechanistic Classification of Clinical Phenotypes in Neuroblastoma. Pediatr. Blood Cancer, 65. S. S87 - 2. HOBOKEN: WILEY. ISSN 1545-5017

Ackermann, S., Cartolano, M., Hero, B., Roderwieser, A., Bartenhagen, C., Rosswog, C., Hertwig, F., Simon, T., Eggert, A., Speleman, F., Buettner, R., O'sullivan, R., Thomas, R., Berthold, F., Vandesompele, J., Schramm, A., Westermann, F., Schulte, J., Peifer, M. and Fischer, M. (2018). A Mechanistic Classification of Clinical Phenotypes in Neuroblastoma. Pediatr. Blood Cancer, 65. S. S234 - 1. HOBOKEN: WILEY. ISSN 1545-5017

2017

Hero, B., Simon, T., Lode, H., Eggert, A. and Berthold, F. (2017). Feasibility and Toxicity of Busulfan and Melphalan Conditioning Regimen in the Context of the German Induction Chemotherapy. Pediatr. Blood Cancer, 64. S. S34 - 2. HOBOKEN: WILEY. ISSN 1545-5017

Schmidt, M. C., Hero, B., Decarolis, B., Eggert, A., Berthold, F., Drzezga, A. and Simon, T. (2017). I-131-mIBG therapy in high-risk neuroblastoma patients at end of induction chemotherapy. Eur. J. Nucl. Med. Mol. Imaging, 44. S. S772 - 1. NEW YORK: SPRINGER. ISSN 1619-7089

Simon, T., Schmidt, M., Decarolis, B., Eggert, A., Berthold, F. and Hero, B. (2017). I-131-Meta-Iodobenzylguanidine (MIBG) Therapy Improves Survival in High-Risk Neuroblastoma Patients with MIBG Positive Residual Metastatic Disease. Pediatr. Blood Cancer, 64. S. S33 - 2. HOBOKEN: WILEY. ISSN 1545-5017

2016

Schmidt, M. C., Hero, B., Decarolis, B., Eggert, A., Berthold, F., Drzezga, A. and Simon, T. (2016). I-131-meta-iodobenzylguanidine therapy improves survival in high-risk neuroblastoma patients with I-123-mIBG positive residual metastatic disease. Eur. J. Nucl. Med. Mol. Imaging, 43. S. S31 - 1. NEW YORK: SPRINGER. ISSN 1619-7089

Schulte, J., Schramm, A., Koester, J., Westermann, F., Peifer, M., Fischer, M., Rahmann, S. and Eggert, A. (2016). Mutational dynamics between primary and relapse neuroblastoma involve genes relevant for mesenchymal transition. Oncol. Res. Treat., 39. S. 30 - 32. BASEL: KARGER. ISSN 2296-5262

2015

Deubzer, H., Fabian, J., Opitz, D., Althoff, K., Lodrini, M., Astrahantseff, K., Hero, B., Volland, R., Beckers, A., De Preter, K., Patil, N., Abba, M., Wuenchel, J., Thole, T., Hu, J., Schweitzer, L., Mechtersheimer, G., Carter, D., Cheung, B., Popanda, O., von Deimling, A., Henrich, K. O., Westermann, F., Schwab, M., Koster, J., Versteeg, R., Marshall, G., Speleman, F., Zoeller, M., Allgayer, H., Fischer, M., Berthold, F., Kulozik, A., Witt, O., Schulte, J. and Eggert, A. (2015). MYCN TRANSCRIPTIONALLY REPRESSES CD9 TO TRIGGER AN INVASION-METASTASIS CASCADE IN NEUROBLASTOMA. Pediatr. Blood Cancer, 62. S. S150 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017

Eggert, A., Schramm, A., Koester, J., Assenov, Y., Kristina, A., Engesser, A., Kahlert, Y., Theissen, J., Hero, B., Roels, F., Peifer, M., Astrahantseff, K., Depreter, K., Lode, H., Speleman, F., Schmezer, P., Westermann, F., Rahmann, S., Fischer, M. and Schulte, J. (2015). INTEGRATED GENOMIC ANALYSIS IDENTIFIES SPECIFIC ALTERATIONS AND ACTIVATION OF YAP IN RELAPSED NEUROBLASTOMA. Pediatr. Blood Cancer, 62. S. S145 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017

Hero, B., Simon, T., Volland, R., Eggert, A., Fischer, M. and Berthold, F. (2015). BENIGN COURSE OF DISEASE IN LOCALIZED NEUROBLASTOMA SHOWING RELAPSE OR PROGRESSION. Pediatr. Blood Cancer, 62. S. S178 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017

2013

Schulte, J. H., Schulte, S., Heukamp, L. C., Astrahantseff, K., Stephan, H., Fischer, M., Schramm, A. and Eggert, A. (2013). Targeted Therapy for Neuroblastoma: ALK Inhibitors. Klinische Padiatr., 225 (6). S. 303 - 309. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3824

This list was generated on Thu Mar 28 12:59:56 2024 CET.